- Home
- OFG vs ZLAB Comparison
OFG vs ZLAB Comparison
Compare OFG & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OFG | ZLAB |
|---|---|---|
| Founded | 1964 | 2013 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.0B |
| IPO Year | 2012 | 2017 |
Fundamental Metrics
Financial Performance| Metric | OFG | ZLAB |
|---|---|---|
| Price | $50.49 | $20.03 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 5 |
| Target Price | $45.17 | ★ $49.60 |
| AVG Volume (30 Days) | 415.9K | ★ 851.8K |
| Earning Date | 04-21-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.12% | N/A |
| EPS Growth | 8.27 | ★ 38.46 |
| EPS | ★ 1.26 | N/A |
| Revenue | N/A | ★ $460,156,000.00 |
| Revenue This Year | $11.56 | $9.75 |
| Revenue Next Year | $1.29 | $26.03 |
| P/E Ratio | $40.60 | ★ N/A |
| Revenue Growth | N/A | ★ 15.33 |
| 52 Week Low | $35.71 | $15.96 |
| 52 Week High | $51.42 | $41.20 |
Technical Indicators
Market Signals| Indicator | OFG | ZLAB |
|---|---|---|
| Relative Strength Index (RSI) | 60.11 | 57.93 |
| Support Level | $48.67 | $16.84 |
| Resistance Level | $50.66 | $21.12 |
| Average True Range (ATR) | 0.95 | 0.81 |
| MACD | -0.00 | 0.15 |
| Stochastic Oscillator | 58.01 | 74.49 |
Price Performance
Historical ComparisonAbout OFG OFG Bancorp
OFG Bancorp is a financial holding company, through its subsidiaries provides banking and financial services. It operates through three segments namely Banking, Wealth Management, and Treasury. It serves to clients such as commercial, consumer, auto, and mortgage lending, checking and savings accounts, financial planning, insurance, financial services, and investment brokerage, and corporate and individual trust and retirement services. The company derives maximum revenue from Banking Segment. It provides services in the region of Puerto Rico.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.